Haisco Pharmaceutical Group Co., Ltd.

This study is testing whether the experimental drug HSK47388 can help control symptoms in adults with moderate-to-severe ulcerative colitis. Researchers will compare the drug against a placebo in 150 participants to see if it reduces bowel inflammation and improves symptoms. The …

This early-stage study is testing a new oral medication called HSK42360 in children and teenagers whose brain tumors have returned after standard treatment. The main goals are to find a safe dose and understand how the drug is processed by the body. The trial is for patients aged…

This study is testing whether HSK39297 tablets can help control IgA nephropathy, a kidney disease where protein leaks into urine. About 370 adults with confirmed IgA nephropathy will take either the real tablets or placebo pills for up to 2 years. Researchers will measure how wel…

This is an early-stage study to find a safe dose and see how well a new oral tablet called HSK47977 works for adults with non-Hodgkin lymphoma that has come back or hasn't responded to other treatments. Researchers will test different dose levels in about 110 participants to chec…

This study is testing whether a new daily pill called HSK39297 can help control lupus nephritis, a serious kidney disease caused by lupus. About 105 adults with active kidney inflammation will take either the real pill or a placebo, along with standard care, to see if it reduces …

This study is testing an experimental injection called HSK21542 to see if it works better and causes fewer side effects than morphine for pain after hip replacement surgery. It will involve 405 adults who have just had surgery and are in significant pain. Participants will be ran…

This early-stage study aims to understand how a potential drug for a rare blood disease (PNH) is processed by the body in people with mild to moderate liver problems. It will compare drug levels and safety in 24 participants, some with liver impairment and some with normal liver …